# Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors

> **NCT07290946** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Christian von Buchwald** · enrollment: 100 (estimated)

## Conditions studied

- Xerostomia Due to Hyposecretion of Salivary Gland
- Xerostomia Due to Radiotherapy
- Sjögren´s Syndrome

## Interventions

- **DRUG:** ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07290946
- **Lead sponsor:** Christian von Buchwald
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-06
- **Final completion:** 2028-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07290946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07290946, "Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07290946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*